You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNA methyltransferase inhibitors

Showing 1 - 25 of 9,227
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-Resistant Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial in Buffalo

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 27, 2022

MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

Active, not recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Neoplasm
  • Azacitidine Subcutaneous Injection or Intravenous Infusion
  • +2 more
  • Miami, Florida
  • +4 more
Jun 20, 2022

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

Not yet recruiting
  • Advanced Breast Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 12, 2022

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Mar 23, 2022

Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)

Active, not recruiting
  • Colorectal Cancer
  • Temozolomide + Olaparib
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 17, 2022

O6-methylguanine-DNA Methyltransferase Promoter Methylation and

Active, not recruiting
  • Sarcoma
  • O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
  • Naples, Campania, Italy
    National Cancer Institute of Naples
May 14, 2021

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Melanoma (Skin) Trial in Dijon, Thionville, Vandœuvre-lès-Nancy (Blood sampling)

Active, not recruiting
  • Melanoma (Skin)
  • Blood sampling
  • Dijon, France
  • +3 more
Mar 29, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 1, 2021

    Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

    Recruiting
    • Metastatic or Locally Advanced Unresectable Solid Tumors
    • Houston, Texas
    • +4 more
    Jul 7, 2022

    Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

    Recruiting
    • Neoplasms
    • Solid Tumors
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Hormone Receptor Positive Breast Carcinoma, Breast Tumors, Tumors, Breast Trial in Italy (Liquid biopsy and CT scan)

    Recruiting
    • Hormone Receptor Positive Breast Carcinoma
    • +6 more
    • Liquid biopsy and CT scan
    • Bergame, Bergamo, Italy
    • +6 more
    Apr 13, 2023

    Circulating Tumor DNA Kinetics in Immuno-oncology

    Completed
    • Head and Neck Cancer
    • +4 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      May 16, 2022

      MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      Ovarian Cancer Trial in Villejuif (AsiDNA, Niraparib, Olaparib)

      Recruiting
      • Ovarian Cancer
      • Villejuif, Val De Marne, France
        Gustave Roussy
      Sep 27, 2021

      Non Small Cell Lung Cancer Trial in Newcastle Upon Tyne (Radiotherapy, Olaparib Oral Tablet [Lynparza], AZD1390)

      Recruiting
      • Non Small Cell Lung Cancer
      • Radiotherapy
      • +5 more
      • Newcastle Upon Tyne, United Kingdom
        Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust
      Sep 20, 2022

      Tumors, Solid Tumors Trial run by the NCI (TdCyd)

      Suspended
      • Neoplasms
      • Solid Tumors
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 6, 2022

      Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung

      Completed
      • Non-small-cell Lung Cancer
      • +2 more
      • DNA sequencing
      • Aalborg, Denmark
        Dept. of Oncology, Aalborg University Hospital
      Aug 3, 2021

      Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy

      Recruiting
      • Myelodysplastic Syndromes
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 31, 2023

        Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint

        Recruiting
        • Relapsed/Refractory Non-Hodgkin Lymphoma
        • Advanced Solid Tumors
        • Beijing, Beijing, China
          Biotherapeutic Department, Chinese PLA General Hospital
        Apr 8, 2022

        Immunotherapy, Refractory Leukemia, Relapsed Adult AML Trial in Suzhou (Visilizumab)

        Recruiting
        • Immunotherapy
        • +3 more
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University
        Dec 2, 2021

        Breast Cancer Trial in France (next-generation sequencing (NGS))

        Active, not recruiting
        • Breast Cancer
        • next-generation sequencing (NGS)
        • Metz, France
        • +9 more
        Aug 25, 2021

        Advanced Rectal Cancer Trial in Seoul (Capecitabine plus temozolomide VS Capecitabine)

        Unknown status
        • Advanced Rectal Cancer
        • Capecitabine plus temozolomide VS Capecitabine
        • Seoul, Songpa, Korea, Republic of
          Asan Medical Center
        Jan 17, 2021